Enteris Biopharma, Inc. has been absolutely fantastic. They went above and beyond my expectations to deliver exceptional results. Their team is highly skilled and dedicated. I am extremely satisfied with their services and would highly recommend them for any biopharmaceutical needs.
👍 Enteris Biopharma, Inc. did an amazing job with my project. Their team is incredibly skilled and dedicated. They guided me through the entire process and ensured that everything went smoothly. I am very impressed with the services provided and would definitely recommend them to others. 👏
I recently used the services of a biopharmaceutical company for my project, and I must say I was impressed with the professionalism and expertise displayed. They delivered exceptional results and exceeded my expectations. The team understood my requirements well and provided tailored solutions. I would highly recommend their services.
Enteris Biopharma, Inc. is a top-notch biopharmaceutical company 🌟. The team is highly skilled and dedicated to delivering exceptional results. I am very impressed with their services and would highly recommend them for any biopharmaceutical projects.
The services provided by Enteris Biopharma, Inc. are excellent. Their team of experts is dedicated and knowledgeable, ensuring that every project is completed with precision and efficiency. The company's commitment to quality is evident in their attention to detail and strong work ethic. I highly recommend Enteris Biopharma, Inc. for all your biopharmaceutical needs.
I recently availed the services of a biopharmaceutical company and was very impressed with the professionalism they exhibited. The team was knowledgeable and skilled, and they delivered great results. I would definitely recommend their services to others.
Enteris Biopharma, Inc. is a company that provides exceptional biopharmaceutical services. They have a highly knowledgeable and dedicated team that strives for excellence in every project. I am extremely satisfied with their work and highly recommend them.
I recently worked with Enteris Biopharma, Inc. on a project, and I must say they did an outstanding job. The team was highly professional, knowledgeable, and efficient. I am extremely satisfied with their services and would gladly work with them again.
Enteris Biopharma, Inc. exceeded my expectations with their exceptional services. The team was incredibly dedicated and skilled. They provided tailored solutions based on my requirements and ensured timely delivery. I am highly satisfied and would highly recommend their services.
I had an amazing experience working with Enteris Biopharma, Inc. 😊 Their team was incredibly helpful and knowledgeable. The entire process was smooth and hassle-free. I am extremely satisfied with the services provided and would highly recommend them.
Enteris BioPharma, Inc. is a clinical stage biopharmaceutical Contract Development and Manufacturing Organization (CDMO) that specializes in oral peptide drug delivery technology. The company's Peptelligence® platform is designed to improve the bioavailability and efficacy of orally administered drugs, particularly peptides.
Peptides are short chains of amino acids that play a critical role in many biological processes. They have been shown to be effective in treating a wide range of diseases, including diabetes, cancer, and autoimmune disorders. However, because peptides are rapidly degraded by enzymes in the digestive tract and have poor absorption rates when taken orally, they must be delivered through injections or other invasive methods.
Enteris BioPharma's Peptelligence® platform overcomes these challenges by using proprietary technologies to protect peptides from degradation in the digestive tract and enhance their absorption into the bloodstream. This allows for more convenient and patient-friendly oral delivery of peptide-based therapies.
The company has several ongoing partnerships with pharmaceutical companies to develop new oral peptide-based drugs using its Peptelligence® platform. One such partnership is with Cara Therapeutics to develop an oral formulation of KORSUVA™ (CR845/difelikefalin), a novel kappa opioid receptor agonist being developed for the treatment of pruritus (itching) associated with chronic kidney disease.
In addition to its work on oral peptide drug delivery technology, Enteris BioPharma also offers contract development and manufacturing services for small molecules and other biologics. The company's state-of-the-art facility in Boonton, New Jersey includes capabilities for formulation development, analytical testing, clinical trial material manufacturing, commercial scale-up production, packaging/labeling services as well as stability testing.
Enteris BioPharma was founded in 2013 by Joel Tune - who previously co-founded Unigene Laboratories - along with Sanofi veteran Rajiv Khosla who serves as CEO today . Since then it has grown rapidly thanks to its innovative approach towards developing new treatments that can be delivered orally rather than through injections or other invasive methods.
Overall Enteris Biopharma is an innovative CDMO that specializes in developing cutting-edge technologies for delivering peptides via an oral route which could revolutionize how we treat various diseases like diabetes or cancer among others while also offering contract development & manufacturing services for small molecules & biologics alike making it one-stop-shop solution provider for all your pharmaceutical needs!
enterisbiopharma.com
